Back to Filings
Quince Therapeutics, Inc.(QNCX)
3
Pending
Accession Number
0001662170-26-000002
Filing Date
Sector
Non-accelerated filer<br>Smaller reporting company
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
CIK
0001662774
View FilingSEC Index
AI Summary
Coming Soon
AI-generated summary of key insights from this filing

Summary in Development

AI-powered summaries will be available soon

Ask Questions
Coming Soon
Ask questions about this filing and get AI-powered answers

Q&A in Development

Ask questions about this filing soon